MEI Pharma Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML) Thu, 11 Jan 2018 00:00:00 -0800 MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib Mon, 08 Jan 2018 06:00:00 -0800 MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports New Preclinical Studies Demonstrate Repression of MCL-1 and Sensitization to BCL-2 Inhibition in Diffuse Large B-Cell Lymphoma Thu, 21 Dec 2017 06:00:00 -0800 MEI Pharma to Host Annual Meeting of Stockholders Live Webcast from San Diego on November 30th Wed, 22 Nov 2017 06:00:00 -0800 MEI Pharma Reports First Quarter Fiscal Year 2018 Results Quarter highlighted by dosing of first patient in pivotal Phase 3 study of pracinostat and exclusive license agreement for voruciclib Wed, 08 Nov 2017 06:00:00 -0800